-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become one of the largest known epidemics in human history, affecting more than 233 million people worldwide
COVID-19
In a study published in Critical Care, an authoritative journal in the field of critical care medicine, researchers conducted a meta-analysis to assess the impact of early tracheostomy compared with late tracheostomy on outcomes in patients with COVID-19.
From December 1, 2019, to August 24, 2021, researchers searched Medline, Embase, Cochrane and Scopus databases, as well as medRxiv, biORxiv and Research Square databases
This meta-analysis included 14 studies with a total of 2371 tracheostomy patients with COVID-19
CONCLUSIONS: The results of this meta-analysis suggest that early tracheostomy in COVID-19 patients is associated with shorter invasive mechanical ventilation and ICU stay compared with late tracheostomy, without changing patient death rate
The results of this meta-analysis suggest that compared with late tracheostomy, early tracheostomy in COVID-19 patients is associated with shorter invasive mechanical ventilation and ICU stay without changing patient mortality
Original source:
Yun Ji,et al.
Tracheostomy timing and clinical outcomes in ventilated COVID-19 patients: a systematic review and meta-analysisLeave
a comment here
